Bank Of America Corp Dbv Technologies S.A. Transaction History

Bank Of America Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.75 - $0.95 $1,458 - $1,847	-1,945 Reduced 61.26%	1,230 $0
Q4 2023 Feb 14, 2024	BUY	$0.7 - $1.33 $846 - $1,607	1,209 Added 61.5%	3,175 $3,000
Q1 2023 May 12, 2023	SELL	$1.28 - $1.73 $15 - $20	-12 Reduced 0.61%	1,966 $3,000
Q4 2022 Feb 10, 2023	BUY	$1.16 - $1.8 $155 - $241	134 Added 7.27%	1,978 $3,000
Q3 2022 Nov 14, 2022	SELL	$1.77 - $2.76 $4,046 - $6,309	-2,286 Reduced 55.35%	1,844 $3,000
Q2 2022 Aug 12, 2022	BUY	$1.15 - $3.25 $2,760 - $7,800	2,400 Added 138.73%	4,130 $10,000
Q1 2022 May 16, 2022	SELL	$1.22 - $1.77 $1,134 - $1,646	-930 Reduced 34.96%	1,730 $3,000
Q4 2021 Feb 08, 2022	SELL	$1.39 - $5.58 $293 - $1,177	-211 Reduced 7.35%	2,660 $4,000
Q3 2021 Nov 15, 2021	SELL	$4.71 - $5.92 $57,739 - $72,573	-12,259 Reduced 81.02%	2,871 $14,000
Q2 2021 Sep 13, 2021	BUY	$5.32 - $6.53 $80,491 - $98,798	15,130 New	15,130 $83,000

253K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $128M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.